Washington Patent of the Month – December 2025
A breakthrough in pharmaceutical chemistry is paving the way for more reliable and effective mental health treatments. CaaMTech Inc. recently secured a new patent for high-purity crystalline versions of a unique psychedelic compound. This innovation addresses long-standing challenges in drug stability and dosing for emerging therapeutic research.
Advancing Psychedelic Medicine
The innovation focuses on U.S. Patent No. 12497360, titled ‘Crystalline 4-hydroxy-N,N-di-n-propyltryptammonium (4-HO-DPT) salts’. Traditional versions of this compound often suffer from inconsistent purity or poor shelf life. CaaMTech has developed specific crystalline structures that remain stable and predictable. These properties are essential for pharmaceutical manufacturing and clinical trials. By creating a standardized material, the company ensures that researchers can deliver precise doses every time.
Enhancing Reliability and Safety
Stability is a major hurdle when turning complex molecules into viable medicines. Crystalline salts offer better solubility and easier handling during the production process. This technical leap allows for more rigorous testing of the compound’s therapeutic potential. It also reduces the risk of degradation which can impact the safety of a drug. As the medical community explores new ways to treat depression and anxiety, these reliable foundations are critical.
Real-World Impact
The patent signals a shift toward professional-grade psychedelic healthcare. CaaMTech’s work helps move these compounds from experimental labs into regulated clinical settings. Their precise chemical engineering creates a clear path for future drug approvals. This development offers hope for patients seeking modern alternatives to existing psychiatric medications. Reliable chemistry is the first step toward the next generation of mental health care.
Learn More:
Are you developing new or improved products, or thinking of applying for a patent? Did you know your research work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? To find out more, please check out our free online eligibility test.
Feel free to book a quick teleconference with one of R&D Tax specialists if you would like to learn more about R&D Tax Credit opportunities.
Who We Are:
Swanson Reed is one of the largest Specialist R&D Tax Credit advisory firm in the United States. With offices nationwide, we are one of the only firms globally to exclusively provide R&D Tax Credit consulting services to our clients. We have been exclusively providing R&D Tax Credit claim preparation and audit compliance solutions for over 30 years.
Swanson Reed’s Washington office provides R&D tax credit consulting and advisory services to Seattle, Spokane, Tacoma, Vancouver, Bellevue, Kent, Everett, Renton, Federal Way, and Yakima.
Swanson Reed hosts daily free webinars and provides free IRS CE and CPE credits for CPAs. For more information please click here or contact your usual Swanson Reed representative.
What is the R&D Tax Credit?
The Research & Experimentation Tax Credit (or R&D Tax Credit), is a general business tax credit under Internal Revenue Code section 41 for companies that incur research and development (R&D) costs in the United States. The credits are a tax incentive for performing qualified research in the United States, resulting in a credit to a tax return. For the first three years of R&D claims, 6% of the total qualified research expenses (QRE) form the gross credit. In the 4th year of claims and beyond, a base amount is calculated, and an adjusted expense line is multiplied times 14%. Click here to learn more.
R&D Tax Credit Preparation Services
Swanson Reed is one of the only companies in the United States to exclusively focus on R&D tax credit preparation. Swanson Reed provides state and federal R&D tax credit preparation and audit services to all 50 states.
If you have any questions or need further assistance, please call or email our CEO, Damian Smyth on (800) 986-4725.
Feel free to book a quick teleconference with one of our national R&D tax credit specialists at a time that is convenient for you.
R&D Tax Credit Audit Advisory Services
creditARMOR is a sophisticated R&D tax credit insurance and AI-driven risk management platform. It mitigates audit exposure by covering defense expenses, including CPA, tax attorney, and specialist consultant fees—delivering robust, compliant support for R&D credit claims. Click here for more information about R&D tax credit management and implementation.
Our Fees
Swanson Reed offers R&D tax credit preparation and audit services at our hourly rates of between $195 – $395 per hour. We are also able offer fixed fees and success fees in special circumstances. Learn more at https://www.swansonreed.com/about-us/research-tax-credit-consulting/our-fees/
Choose your state










